Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to determine the incidence of severe RSV LRTI requiring hospitalization among infants born \< 35 weeks gestational age for one year of follow-up.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abbott
Collaborators
NCT07552779 · Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19), and more
NCT07297966 · Recurrent Respiratory Tract Infections
NCT06282718 · Acute Respiratory Tract Infection
NCT07041671 · URTI - Viral Upper Respiratory Tract Infection
NCT06788093 · Lower Respiratory Tract Infection, Pneumonia, and more
Site Ref # / Investigator 6185
Curitiba, Paraná
Site Ref # / Investigator 6189
Ribeirão Preto, São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions